SNC-Lavalin Pharma and GlaxoSmithKline

May 7 newsy GlaxoSmithKline.jpg

SNC-Lavalin Pharma and GlaxoSmithKline took home the Prix Léonard for industry recently at the Grands Prix du génie conseil-québécois, held in Montreal. The two firms were honoured for their teamwork on the expansion project of GlaxoSmithKline’s Sainte-Foy vaccine production facility. The project was realized in the space of 15 months and the larger facility has enabled the company to expand its work on flu vaccines. From left to right: François Vallerand, A.I.B., vice president, business development Dale-Parizeau LM; Pierre Hénault, director, mechanical and electrical engineering, building engineering and construction management division SNC-Lavalin Inc.; Jean-François Harpin, vice president, operations SNC-Lavalin Pharma, a division of SNC-Lavalin Inc.; René Brisebois, assistant director, mechanical and electrical engineering, building engineering and construction management division SNC-Lavalin Inc.; and Maryse St-Georges, project director, engineering GlaxoSmithKline Biologicals.